Lucinactant in neonatal respiratory distress syndrome: profile report

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.21, Iss.10, 2005-10, pp. : 5-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lucinactant for the prevention of respiratory distress syndrome in premature infants

By Jordan Brian K Donn Steven M

Expert Review of Clinical Pharmacology, Vol. 6, Iss. 2, 2013-03 ,pp. : 115-121

Informa Healthcare

Access to resources Recommend Favorite

Lucinactant: a novel synthetic surfactant for the treatment of respiratory distress syndrome

By Donn Steven M

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 3, 2005-03 ,pp. : 329-334

Informa Healthcare

Access to resources Recommend Favorite

Rituximab: Adult respiratory distress syndrome: case report

Reactions Weekly, Vol. 1, Iss. 1086, 2006-01 ,pp. : 22-23

Adis International

Access to resources Recommend Favorite

Cyclophosphamide: Adult respiratory distress syndrome: case report

Reactions Weekly, Vol. 1, Iss. 1173, 2007-01 ,pp. : 12-13

Adis International

Access to resources Recommend Favorite

Lithium: Acute respiratory distress syndrome: case report

Reactions Weekly, Vol. 1, Iss. 1352, 2011-01 ,pp. : 25-25

Adis International

Access to resources Recommend Favorite